BARINTHUS BIOTHERAPEUTICS PL (BRNS) Stock Technical Analysis
NASDAQ:BRNS • US91864C1071
Taking everything into account, BRNS scores 0 out of 10 in our technical rating. BRNS scores bad on all fronts: it is a bad performer in the overall market and both the medium and short term pictures are negative.
- Both the long and short term trends are negative. It is better to avoid buying stocks with negative trends.
- When comparing the yearly performance of all stocks, BRNS is a bad performer in the overall market: 88% of all stocks are doing better.
- BRNS is one of the lesser performing stocks in the Biotechnology industry. 66% of 521 stocks in the same industry do better.
- BRNS is currently trading near the lower end of its 52 week range, which is not a good sign. Certainly not because the S&P500 Index is trading near new 52 week highs at the moment.
- In the last month BRNS has a been trading in the 0.56 - 0.75 range, which is quite wide. It is currently trading near the lows of this range.
- Volume is considerably higher in the last couple of days.
Although the technical rating is bad, BRNS does present a nice setup opportunity. Prices have been consolidating lately. There is very little resistance above the current price.
More info and screens
0.62
5 important resistance areas can be observed.
- Resistance @0.67 from a horizontal line in the daily time frame.
- A resistance zone ranging from 0.73 to 0.76. This zone is formed by a combination of multiple trend lines and important moving averages in multiple time frames.
- Resistance @0.93 from a trend line in the daily time frame.
- Resistance @1.12 from a trend line in the weekly time frame.
- Resistance @1.49 from a horizontal line in the weekly time frame.
The Technical Rating and Setup analysis above combine different indicators and trends in different timeframes. Individual signals from indicators may give more contradictive signals and should always be interpreted in the more global context.
| Indicator | Value | Signal | Comment |
|---|---|---|---|
| ChartMill Long Term Trend Indicator | DOWN | NEGATIVE | The long term trend for BRNS is down. |
| ChartMill Short Term Trend Indicator | DOWN | NEGATIVE | The short term trend for BRNS is down. |
| ChartMill Relative Strength | 12.69 | NEGATIVE | BRNS has a low relative strength, it was outperformed by 87.31% off all stocks on the market. |
| Simple Moving Average/SMA (20) | DOWN | NEGATIVE | The current price of BRNS is below a declining SMA(20). |
| Simple Moving Average/SMA (50) | DOWN | NEGATIVE | The current price of BRNS is below a declining SMA(50). |
| Simple Moving Average/SMA (200) | DOWN | NEGATIVE | The current price of BRNS is below a declining SMA(200). |
| Relative Strength Index/RSI (14) | 40.94 | NEUTRAL | The RSI value for BRNS is a neutral value. |
| Moving Average Convergence Divergence/MACD (12, 26, 9) | -0.01 | NEGATIVE | The MACD value suggests BRNS has a negative trend, although the MACD value is rising. |
| Stochastics (14,3) | 32.46 | NEUTRAL | The Stochastics value for BRNS is a neutral value. |
| Average True Range in percent/ATR (20) | 8.99 | HIGH VOLATILITY | The high ATR as a percentage value for BRNS suggests high volalility. |
| Average Directional Index/ADX (14) | 27.82 | POSITIVE | The high ADX value value for BRNS suggests a strong trend. |
NASDAQ:BRNS (2/20/2026, 8:19:44 PM)
0.625
+0.05 (+7.76%)
BARINTHUS BIOTHERAPEUTICS PL / BRNS FAQ
What is the ChartMill technical rating of BARINTHUS BIOTHERAPEUTICS PL (BRNS) stock?
ChartMill assigns a technical rating of 0 / 10 to BRNS.
What is the trend direction for BRNS stock?
The current trend direction for BARINTHUS BIOTHERAPEUTICS PL (BRNS) is Bearish.
What is the RSI signal for BARINTHUS BIOTHERAPEUTICS PL (BRNS) stock?
BARINTHUS BIOTHERAPEUTICS PL (BRNS) has an RSI value of 40.9352. This indicates that the stock is currently neutral.
What is the MACD signal for BRNS stock?
The MACD indicator for BARINTHUS BIOTHERAPEUTICS PL (BRNS) has a value of -0.00919094, indicating a bearish trend.
What is the buy/sell signal for BRNS stock?
The buy/sell signal for BARINTHUS BIOTHERAPEUTICS PL (BRNS) is sell as both the short term and long term trends are negative.